English | 繁體

Search in the results

UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
Anti-Tumour Effects of a Human & Mouse Cross-Reactive’ Anti-ADAM17 Antibody in a Pancreatic Cancer Model In Vivo Conference paper
Yuen, S. M., Ye, J., Murphy, G., Xie, R., Kwok, H. F.. Anti-Tumour Effects of a Human & Mouse Cross-Reactive’ Anti-ADAM17 Antibody in a Pancreatic Cancer Model In Vivo[C]:International Association of Physical Chemists, 2016, 28-28.
Authors:  Yuen, S. M.;  Ye, J.;   Murphy, G.;  Xie, R.;  Kwok, H. F.
Favorite |  | Submit date：2022/06/02
TACE  TNF-Alpha  Anti-ADAM17 Antibody  Pancreatic Mouse Model  
Discovery and Development of Therapeutic TACE (ADAM17) Antibodies Conference paper
Kwok, H. F., Botkjaer, K., Tape, C., Huang, Y., McCafferty, J., Murphy, G.. Discovery and Development of Therapeutic TACE (ADAM17) Antibodies[C], 2015.
Authors:  Kwok, H. F.;  Botkjaer, K.;  Tape, C.;  Huang, Y.;  McCafferty, J.; et al.
Favorite |  | Submit date：2022/06/02
Cross-Reactive  Anti-TACE Antibody  Mouse Models  
Development of a ‘mouse and human cross-reactive’ affinity-matured exosite inhibitory human antibody specific to TACE (ADAM17) for cancer immunotherapy Journal article
Kwok, H. F., Botkjaer, K. A., Tape, C. J., Huang, Y., McCafferty, J., Murphy, G.. Development of a ‘mouse and human cross-reactive’ affinity-matured exosite inhibitory human antibody specific to TACE (ADAM17) for cancer immunotherapy[J]. Protein engineering, design & selection : PEDS Oxford University Press, 2014, 179-190.
Authors:  Kwok, H. F.;  Botkjaer, K. A.;  Tape, C. J.;  Huang, Y.;  McCafferty, J.; et al.
Favorite |   IF:2.6/2.0 | Submit date：2022/06/02
anti-TACE antibody  exosite  immunoreactivity  phage-display randomization libraries  sub-nanomolar affinity  
Development of a 'mouse and human cross-reactive' affinity-matured exosite inhibitory human antibody specific to TACE (ADAM17) for cancer immunotherapy Journal article
Kwok H.F., Botkjaer K.A., Tape C.J., Huang Y., McCafferty J., Murphy G.. Development of a 'mouse and human cross-reactive' affinity-matured exosite inhibitory human antibody specific to TACE (ADAM17) for cancer immunotherapy[J]. Protein engineering, design & selection : PEDS Oxford University Press, 2014, 27(6), 179-190.
Authors:  Kwok H.F.;  Botkjaer K.A.;  Tape C.J.;  Huang Y.;  McCafferty J.; et al.
Favorite | TC[WOS]:29 TC[Scopus]:30 | Submit date：2018/12/19
Anti-tace Antibody  Exosite  Immunoreactivity  Phage-display Randomization Libraries  Sub-nanomolar Affinity